InternationalUSRemember you can easily switch between MIP US and MIP International at any time

UPC scenario 5: Enforcing a patent inside and outside the UPC


In the latest in our series of UPC scenarios, Laura Whiting and Inmaculada Lorenzo explore the options for a pharmaceutical patent owner faced with a potential infringer manufacturing its product in Spain

Innovator pharmaceutical companies seeking to keep first entrant generic competitors off the market for a blockbuster drug are frequent litigators before the national patent courts of Europe. With the advent of the Unitary Patent and Unified Patent Court (UPC) –...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog


null null null

nullnullnull

null

July /August 2019

AI and IP: the view from above

Managing IP speaks to the directors of WIPO and the EUIPO to gauge their views on AI, asking how the technology can help the offices be more efficient and whether job losses are inevitable



Most read articles

Supplements